Skip to content
  • Sunday, 26 July 2026
  • 4:35 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Apr 11, 2026 0

This groundbreaking research from the Johns Hopkins Kimmel Cancer Center marks a significant stride in the quest for more effective…

Read More
Clinical Diagnostics & Pathology

Johns Hopkins Researchers Unveil Groundbreaking Epigenetic Instability Index to Revolutionize Early Cancer Detection Through Advanced Liquid Biopsy

Reynand Amr Wu Apr 4, 2026 0

A pioneering development from researchers at the Johns Hopkins Kimmel Cancer Center is set to significantly enhance the accuracy and…

Read More
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Mar 27, 2026 0

This groundbreaking research from the Johns Hopkins Kimmel Cancer Center heralds a new era in early cancer detection, introducing a…

Read More
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Mar 20, 2026 0

Researchers at Johns Hopkins Kimmel Cancer Center have introduced a groundbreaking advancement in liquid biopsy technology, demonstrating that measuring the…

Read More
Beneath Farmland in New South Wales, an Ancient Rainforest Yields Unprecedented Fossil Discoveries in Iron-Rich RocksNavigating the Quantum Frontier: Five Essential GitHub Repositories for Mastering Quantum Machine LearningFDA reverses course, agrees to review Moderna’s mRNA flu vaccineSai Life Sciences plans to recruit 700+ professionals in FY27 as Indian CRDMO demand accelerates
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ